PharmaEssentia Statistics

Total Valuation

PharmaEssentia has a market cap or net worth of EUR 5.93 billion. The enterprise value is 5.35 billion.

Market Cap	5.93B
Enterprise Value	5.35B

Important Dates

The next estimated earnings date is Thursday, February 27, 2025.

Earnings Date	Feb 27, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+6.10%
Shares Change (QoQ)	-0.02%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	255.72M

Valuation Ratios

The trailing PE ratio is 113.86.

PE Ratio	113.86
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	8.14
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 129.29, with an EV/FCF ratio of 433.35.

EV / Earnings	102.69
EV / Sales	21.90
EV / EBITDA	129.29
EV / EBIT	171.50
EV / FCF	433.35

Financial Position

The company has a current ratio of 12.31, with a Debt / Equity ratio of 0.04.

Current Ratio	12.31
Quick Ratio	11.53
Debt / Equity	0.04
Debt / EBITDA	0.73
Debt / FCF	2.34
Interest Coverage	46.32

Financial Efficiency

Return on equity (ROE) is 7.39% and return on invested capital (ROIC) is 2.57%.

Return on Equity (ROE)	7.39%
Return on Assets (ROA)	2.37%
Return on Capital (ROIC)	2.57%
Revenue Per Employee	1.79M
Profits Per Employee	397,764
Employee Count	131
Asset Turnover	0.30
Inventory Turnover	0.77

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +67.69% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+67.69%
50-Day Moving Average	18.71
200-Day Moving Average	16.50
Relative Strength Index (RSI)	54.70
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, PharmaEssentia had revenue of EUR 234.87 million and earned 52.11 million in profits. Earnings per share was 0.16.

Revenue	234.87M
Gross Profit	204.58M
Operating Income	30.00M
Pretax Income	54.42M
Net Income	52.11M
EBITDA	33.07M
EBIT	30.00M
Earnings Per Share (EPS)	0.16

Full Income Statement

Balance Sheet

The company has 588.07 million in cash and 28.86 million in debt, giving a net cash position of 559.22 million.

Cash & Cash Equivalents	588.07M
Total Debt	28.86M
Net Cash	559.22M
Net Cash Per Share	n/a
Equity (Book Value)	736.35M
Book Value Per Share	2.22
Working Capital	640.55M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 43.39 million and capital expenditures -31.04 million, giving a free cash flow of 12.35 million.

Operating Cash Flow	43.39M
Capital Expenditures	-31.04M
Free Cash Flow	12.35M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 87.10%, with operating and profit margins of 12.77% and 22.19%.

Gross Margin	87.10%
Operating Margin	12.77%
Pretax Margin	23.17%
Profit Margin	22.19%
EBITDA Margin	14.08%
EBIT Margin	12.77%
FCF Margin	5.26%

Dividends & Yields

PharmaEssentia does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-6.10%
Shareholder Yield	-6.10%
Earnings Yield	n/a
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

PharmaEssentia has an Altman Z-Score of 29.42.

Altman Z-Score	29.42
Piotroski F-Score	n/a